BCM
SNTI icon

Bridgeway Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Bridgeway Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,500
Closed -$54.7K – 1338
2024
Q1 		$54.7K Hold
14,500
– – ﹤0.01% 1261
2023
Q4 		$95.7K Hold
14,500
– – ﹤0.01% 1247
2023
Q3 		$61.6K Hold
14,500
– – ﹤0.01% 1284
2023
Q2 		$90.4K Buy
14,500
+5,000
+53% +$48.8K ﹤0.01% 1272
2023
Q1 		$112K Hold
9,500
– – ﹤0.01% 1216
2022
Q4 		$134K Buy
9,500
+7,000
+280% +$171K ﹤0.01% 1172
2022
Q3 		$54K Buy
+2,500
New +$49.3K ﹤0.01% 1345

Other funds holding SNTI

8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return